NCT00372593 2021-03-24Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaChildren's Oncology GroupPhase 3 Completed1,070 enrolled 18 charts 2 FDA
NCT00691015 2017-06-28Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantBarbara Ann Karmanos Cancer InstitutePhase 2 Completed48 enrolled 12 charts